MINDERA HEALTH Trademark

Trademark Overview


On Thursday, January 5, 2023, a trademark application was filed for MINDERA HEALTH with the United States Patent and Trademark Office. The USPTO has given the MINDERA HEALTH trademark a serial number of 97742599. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, May 2, 2024. This trademark is owned by Mindera Corporation. The MINDERA HEALTH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and medical research, namely, analysis of cells, proteins and nucleic acids; Software as a service (SaaS) services and platform as a service (PaaS) featuring computer software platforms using machine-learning algorithms for collecting, storing, analyzing, sharing, reporting, and processing data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostic research, clinical research, drug development, drug development research, drug efficacy research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Hosting an online network service in the nature of an website that enables users to store, analyze and share data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory res...
mindera health

General Information


Serial Number97742599
Word MarkMINDERA HEALTH
Filing DateThursday, January 5, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, May 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of an incomplete circle with the stylized wording "MINDERA HEALTH" interrupting the circle and wording extending into the circle.
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"HEALTH"
Goods and ServicesScientific and medical research, namely, analysis of cells, proteins and nucleic acids; Software as a service (SaaS) services and platform as a service (PaaS) featuring computer software platforms using machine-learning algorithms for collecting, storing, analyzing, sharing, reporting, and processing data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostic research, clinical research, drug development, drug development research, drug efficacy research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Hosting an online network service in the nature of an website that enables users to store, analyze and share data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Clinical diagnostic and consultation services for research purposes in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Computer services, namely, cloud hosting provider services and onsite provider services in the nature of technical support services, namely, installation, administration, and troubleshooting of problems for computer software for storing, analyzing and sharing information in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Providing an online network service in the nature of an website that enables users to store, access, manage, analyze and share data for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Database design and development; RNA analysis services for scientific research purposes involving the identification and treatment of disease; Medical research services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, January 29, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMindera Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92123

Trademark Events


Event DateEvent Description
Monday, January 9, 2023NEW APPLICATION ENTERED
Tuesday, January 31, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, October 17, 2023NON-FINAL ACTION WRITTEN
Tuesday, October 17, 2023NON-FINAL ACTION E-MAILED
Tuesday, October 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 16, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sunday, January 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 28, 2023ASSIGNED TO EXAMINER
Monday, April 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 2, 2024LETTER OF SUSPENSION E-MAILED
Thursday, May 2, 2024SUSPENSION LETTER WRITTEN
Thursday, May 2, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 16, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED